Skip to main content
Premium Trial:

Request an Annual Quote

EU Epigenomics Consortium Taps Genomatix for Next-Gen Sequence Data Analysis

Premium

Genomatix said this week that its software has been selected to analyze next-generation sequence data for the Blueprint of Hematopoietic Epigenomes consortium, an EU-funded project focused on research into blood-based diseases like leukemia.

Genomatix also said that it will develop a graphical user interface for the consortium that will help researchers view the project's results.

Genomatix is one of 41 partners in the €40 million ($54 million) Blueprint project, which aims to generate 100 reference epigenomes and study their underlying biological processes and mechanisms in relation to health and disease.

The project kicked off in late September and is slated to run through March 2016. It has received €30 million in funding from the European Commission and will receive an additional contribution of nearly €10 million from collaborators.

Specifically, the consortium will study different types of hematopoietic cells in samples taken from healthy individuals and leukemia patients. The researchers are hoping to identify epigenetic targets for drugs as well as to discover and validate markers for diagnostic use.

Korbinian Grote, Genomatix's product manager, said in a statement that the project will help the company "further improve our existing line of next-generation sequencing analysis products" as well as implement "new ideas tailored towards the integration of epigenomic data into our interfaces and visualizations."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more